Article
An engineered Axl 'decoy receptor' effectively silences the Gas6-Axl signaling axis.
Nature chemical biology - 1 Nov 2014
Kariolis Mihalis S, Miao Yu Rebecca, Jones Douglas S, Kapur Shiven, Mathews Irimpan I, Giaccia Amato J, Cochran Jennifer R
Abstract excerpt
Aberrant signaling through the Axl receptor tyrosine kinase has been associated with a myriad of human diseases, most notably metastatic cancer, identifying Axl and its ligand Gas6 as important therapeutic targets. Using rational and combinatorial approaches, we engineered an Axl 'decoy receptor'...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
